TAK - Takeda Pharmaceutical Non-GAAP EPS of ¥443.00, revenue of ¥3528.2B; raises FY outlook
2025-01-30 01:49:20 ET
More on Takeda Pharmaceutical:
- Takeda Pharmaceutical: Dividend Yield Is High But Hides Pitfalls Especially For US Investors
- Ascentage Pharma raises $126M via U.S. IPO (update)
- Takeda-backed Ascentage Pharma sets terms for $170M IPO
- Seeking Alpha’s Quant Rating on Takeda Pharmaceutical
- Historical earnings data for Takeda Pharmaceutical